What is the appropriate cefdinir dosage for a 10‑year‑old child weighing 78 lb (≈35 kg) with streptococcal pharyngitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefdinir Dosing for Streptococcal Pharyngitis in a 10-Year-Old

For a 10-year-old child weighing 78 pounds (35.4 kg) with streptococcal pharyngitis, administer cefdinir 7 mg/kg twice daily for 5 days, which equals approximately 250 mg (5 mL of 250 mg/5 mL suspension) twice daily. 1

Weight-Based Dose Calculation

  • The child weighs 78 pounds, which converts to 35.4 kg. 1
  • Using the FDA-approved dosing of 7 mg/kg every 12 hours, the calculated dose is 35.4 kg × 7 mg/kg = 248 mg per dose, rounded to 250 mg twice daily. 1
  • This translates to 5 mL of the 250 mg/5 mL suspension twice daily for ease of administration. 1
  • The total daily dose is 500 mg, which is well below the maximum of 600 mg per day for pediatric patients. 1

Treatment Duration: 5 Days vs. 10 Days

A 5-day course of cefdinir is equally effective as a 10-day course for streptococcal pharyngitis and offers superior bacteriologic eradication compared to 10 days of penicillin V. 2, 3

  • Clinical trials demonstrate that cefdinir 7 mg/kg twice daily for 5 days achieves a 90% bacteriologic eradication rate versus 72% with penicillin V for 10 days (P < 0.001). 3
  • Clinical cure rates are equivalent between 5-day cefdinir (92%) and 10-day penicillin V (91%), with no difference in adverse event rates. 3
  • The FDA label approves both 5-day and 10-day regimens for pharyngitis/tonsillitis, giving clinicians flexibility based on adherence concerns. 1

Alternative Once-Daily Dosing Option

  • Cefdinir may alternatively be dosed as 14 mg/kg once daily (approximately 500 mg or 10 mL of 250 mg/5 mL suspension once daily) for 10 days, which has equivalent efficacy to twice-daily dosing. 1, 2
  • Once-daily dosing improves adherence but requires a 10-day course rather than 5 days. 1

Clinical Context: Why Cefdinir for Strep Throat?

  • Cefdinir is an appropriate alternative to penicillin or amoxicillin for Group A streptococcal pharyngitis, particularly in patients with penicillin allergy (non-anaphylactic) or recent treatment failure. 4, 5
  • It provides excellent coverage against Streptococcus pyogenes and is stable against beta-lactamases, though this is less relevant for strep throat since S. pyogenes does not produce beta-lactamases. 5, 6
  • The drug has superior palatability compared to penicillin V, which may improve adherence in pediatric patients. 5

Important Caveats and Monitoring

  • Red stools may occur if the child is taking iron supplements or iron-fortified formula, due to a benign drug-iron interaction that produces heme-negative red stools; this is reversible upon discontinuation and does not require workup. 7
  • Diarrhea is the most common adverse effect, occurring in approximately 12.5% of patients, similar to penicillin V (13.6%). 3
  • Cefdinir should be administered without regard to meals, though absorption is slightly reduced with high-fat meals. 1
  • After mixing the suspension, it remains stable at room temperature for 10 days only; any unused portion must be discarded after this period. 1

When Cefdinir Is NOT First-Line

  • Amoxicillin remains the preferred first-line agent for uncomplicated streptococcal pharyngitis at 50–75 mg/kg/day in two divided doses for 10 days (maximum 1,000 mg per dose). 8
  • Cefdinir is reserved for patients with non-anaphylactic penicillin allergy, recent amoxicillin failure, or when adherence concerns favor a shorter 5-day course. 4, 8
  • For true IgE-mediated (Type I) penicillin allergy, clindamycin or azithromycin are preferred over cephalosporins due to potential cross-reactivity. 8, 9

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.